Improved barrier function observed in cultured skin substitutes developed under anchored conditions

Skin Research and Technology

Volumn 14, Issue 4, 2008, Pages 418-424

  Barai, Namrata D ^a   Boyce, Steven T ^a   Hoath, Steven B ^b   Visscher, Marty O ^b   Kasting, Gerald B ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Barrier function; Cultured skin substitutes; Permeability; TEWL; Transepidermal water loss

Indexed keywords

ANIMAL CELL CULTURE; BIOCHEMISTRY; CAPILLARITY; CELLS; CEMENTS; CYTOLOGY; HISTOLOGY; LIQUIDS; PROBABILITY DENSITY FUNCTION; RESERVOIRS (WATER); SOLIDS; STANDARDS;

BARRIER FUNCTION; CULTURED SKIN SUBSTITUTES; PERMEABILITY; TEWL; TRANSEPIDERMAL WATER LOSS;

SKIN;

NICOTINAMIDE;

ARTICLE; CELL GROWTH; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CULTURED SKIN SUBSTITUTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MITOCHONDRIAL RESPIRATION; PERMEABILITY BARRIER; SKIN GRAFT; SKIN PERMEABILITY; SKIN WATER LOSS;

CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CELLS, IMMOBILIZED; FIBROBLASTS; HUMANS; KERATINOCYTES; MATERIALS TESTING; PERMEABILITY; SKIN ABSORPTION; SKIN, ARTIFICIAL; TISSUE ENGINEERING;

EID: 54049123313     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/j.1600-0846.2008.00225.x     Document Type: Article

References (39)

1. Asbill C, Kim N, El-Kattan A, Creek K, Wertz P, Michniak B. Evaluation of a human bio-engineered skin equivalent for drug permeation studies. Pharmaceut Res 2000; 17: 1092-1097.
2. Boelsma E, Ponec M. Basics (guidelines) on cell culture testing for topical/dermatological drugs/products and cosmetics with regard t efficacy anE safety of the preparations. In: Gabard B, et al: eds. Dermatopharmacology of topical preparations. Berlin: Springer-Verlag, 2000: 38-55.
3. Redoulés D, Perie J, ViodéC, Mavon A, Fournier D, Daunes S, Casas C, Lougarre A, De Viguerie N. Slow internal release of bioactive compounds under the effect of skin enzymes. J Invest Dermatol 2005; 125: 270-277.
4. Ponec M, Kempenaar J. The use of skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacol 1995; 8: 49-59.
5. Botham PA, Hayes AW, Moir D. The international symposium on regulatory testing and animal welfare: Recommendations on best scientific practices for acute local skin and eye toxicity testing. ILAR J 2002; 43 (Suppl): S105-S107.
6. Coulomb B, Lebreton C, Dubertret L. The skin equivalent: A model for skin and general pharmacology. In: Maibach HI, Lowe NJ, eds. Models in dermatology. Basel: Karger, 1989: 20-29.
7. Ponec M. Skin constructs for replacement of skin tissues for in vitro testing. Adv Drug Deliv Rev 2002; 54: S19-S30.
8. Duval C, Schmidt R, Regnier M, Facy V, Asselineau DFB. The use of reconstructed human skin to evaluate UV-induced modifications and sunscreen efficacy. Exp Dermatol 2003; 12 (Suppl 2): 64-70.
9. Klausner M, Neal P, Kubilus J. Initial results with EPI-201, a developing in vitro model of human epidermis. J Invest Dermatol 1998; 110: 558 Abstr #513.
10. Boyce ST, Kagan RJ, Greenhalgh DG, Warner P, Yakuboff KP, Palmieri T, Warden GD. Cultured skin substitutes reduce donor skin harvesting in treatment of excised, full-thickness burns. J Trauma 2006; 60: 821-829.
11. Boyce ST, Glatter R, Kitzmiller WJ. Treatment of chronic wounds with cultured cells and biopolymers: A pilot study. Wounds 1995; 7: 24-29.
12. Barai ND, Supp AP, Kasting GB, Boyce ST. Barrier properties of cultured skin substitutes. AAPS PharmSci 2001; 3(S1), No. 3 (Abstract).
13. Barai ND, Supp AP, Boyce ST, Kasting GB, Visscher MO. Improvement of barrier properties in cultured skin substitutes after grafting on athymic mice. Skin Pharmacol Physiol 2007; 20: 21-28.
14. Boyce ST, Supp AP, Harriger MD, Pickens WL, Wickett RR, Hoath SB. Surface electrical capacitance as a noninvasive index of epidermal barrier in cultured skin substitutes in athymic mice. J Invest Dermatol 1996; 107: 82-87.
15. Ponec M, Boelsma E, Gibbs S, Mommaas M. Characterization of reconstructed skin models. Skin Pharmacol Appl Skin Physiol 2002; 15: 4-17.
16. Ponec M, Kempenaar J, Weerheim A. Lack of desquamation -the Achilles heel of the reconstructed epidermis. Int J Cosmet Sci 2002; 24: 263-272.
17. Zghoul N, Fuchs R, Lehr CM, Schaefer UF. Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations. ALTEX 2001; 18: 103-106.
18. Michel M, Germain I, Auger FA. Anchored skin equivalent cultured in vitro. In Vitro Cell Dev Biol 1993; 29A: 834-837.
19. Boyce ST. Design principles for composition and performance of cultured skin substitutes. Burns 2001; 27: 523-533.
20. Boyce ST, Swope VB, Supp AP, Warden GD. Vitamin C regulates keratinocyte viability, epidermal barrier and basement membrane in vitro, and reduces wound contraction after grafting of cultured skin substitutes. J Invest Dermatol 2002; 118: 565-572.
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65: 55-63.
22. Swope VB, Supp AP, Greenhalgh DG, Warden GD, Boyce ST. Expression of insulin-like growth factor-I by cultured skin substitutes does not replace the physiologic requirement for insulin in vitro. J Invest Dermatol 2001; 116: 650-657.
23. Franz TJ, Lehman PA. The use of water permeability as a means of validation for skin integrity in in vitro percutaneous absorption studies. J Invest Dermatol 1990; 92: 525.
24. Kasting GB, Filloon TG, Francis WR, Meredith MP. Improving the sensitivity of in vitro skin penetration experiments. Pharmaceut Res 1994; 11: 1747-1754.
25. Banes AJ. Mechanical strain and the mammalian cell. In: Frangos JA, ed. Physical forces and the mammalian cell. San Diego: Academic Press, 1993: 81-124.
26. Bloomfield SA. Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exerc 1997; 29: 197-206.
27. Lambert CA, Soudant EP, Nusgens BV, Lapiere CM. Pretranslational regulation of extracellular matrix macromolecules and collagenase expression in fibroblasts by mechanical forces. Lab Invest 1992; 66: 441-451.
28. Hatamochi A, Aumailey M, Mauch C, Chu M-L, Timpl R, Krieg T. Regulation of collagen VI expression in fibroblasts. J Biol Chem 1989; 264: 3494-3499.
29. Chiquet M, Matthison M, Koch M, Tannheimer M, Chiquet-Ehrismann R. Regulation of extracelullar matrix synthesis by mechanical stress. Biochem Cell Biol 1996; 74: 737-744.
30. Chiquet-Ehrismann R, Tannheimer M, Koch M, Brunner A, Spring J, Martin D, Baumgartner S, Chiquet M. Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J Cell Biol 1994; 127: 2093-2101.
31. Takei T, Rivas-Gotz C, Delling CA, Koo JT, Mills I, McCarthy TL, Centrella M, Sumpio BE. Effect of strain on human keratinocytes in vitro. J Cell Physiol 1997; 173: 64-72.
32. Kippenberger S, Bernd A, Loitsch S, Muller J, Guschel M, Kaufmann R. Cyclic stretch up-regulates proliferation and heat shock protein 90 expression in human melanocytes. Pigment Cell Res 1999; 12: 246-251.
33. Gormar FE, Bernd A, Bereiter-Hahn J, Holzmann H. A new model of epidermal differentiation: Induction by mechanical stimulation. Arch Dermatol Res 1990; 282: 22-32.
34. Bernd A, Ramirez-Bosca A, Gormar J. UVA/B and mechanical pressure induce melanin formation by human melanocytes in culture. Eur J Dematol 1992; 2: 450-451.
35. Akhyari P, Fedak PWM, Weisel RD, Lee TJ, Verma S, Mickle DAG, Li R. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 2002; 106 (Suppl I): I137-I142.
36. Lopez VCA, Auger FA, Rompre P, Bouvard V, Germain I. Peripheral anchorage of dermal equivalents. Br J Dermatol 1992; 127: 365-371.
37. Vicanova J, Mommaas M, Mulder AA, Koerten H, Ponec M. Impaired desquamation in the in vitro reconstructed human epidermis. Cell Tissue Res 1996; 286: 115-122.
38. Karande P, Mitragotri S. High throughput screening of transdermal formulations. Pharmaceutical Res 2002; 19: 655-660.
39. Karande P, Jain A, Mitragotri S. Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol 2004; 22: 192-197.